- CME Group received approval to establish its own Futures Commission Merchant (FCM).
- The FIA warns that CME’s approval heightens systemic risk and conflicts of interest due to expanded market roles.
On October 29, the CME Group, a leading player in the derivatives marketplace, received approval from the National Futures Association (NFA) to establish its own Futures Commission Merchant (FCM). The granted approval allows CME Group to manage customer accounts directly and deepen its role in futures trading.
Yet, this move, seen as strategic to better meet clients’ needs, has sparked reactions across the financial industry. The Financial Industry Association (FIA) has raised concerns about potential systemic risks tied to CME’s expanded functions.
Further, the FIA urged the Commodity Futures Trading Commission (CFTC) to set clearer guidelines to manage potential conflicts of interest.
Concerns Over CME’s Role Consolidation
The FIA warns that CME’s consolidation of multiple roles—including trading, clearing, and now customer account management—could lead to conflicts of interest. FIA President Walt Lukken emphasized that managing these functions within a single entity may increase systemic risks. This is an issue the FIA had previously flagged when FTX applied for similar approval. Then Sam Bankman-Fried’s FTX collapsed in November 2022, leading to market uncertainty.
According to FIA President Walt Lukken the CME’s new role “reflects a trend of market consolidation that could impact stability in sensitive financial markets.” The CFTC has also acknowledged similar concerns, especially in the context of heightened market scrutiny.
Highlighted Crypto News Today:
Is Ethereum Price Struggling to Breakout the $2.6K Consolidation?
